Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1677 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Pharmasset Initiates Dosing In Phase 1 PSI-938 Trial

Pharmasset has recently filed an Investigational New Drug Application (IND) with the FDA. Pharmasset said that Purine nucleoside/tide analogs have many of the benefits of pyrimidine nucleoside/tide analogs,